0000899243-21-006348.txt : 20210212
0000899243-21-006348.hdr.sgml : 20210212
20210212174201
ACCESSION NUMBER: 0000899243-21-006348
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210211
FILED AS OF DATE: 20210212
DATE AS OF CHANGE: 20210212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lee Philina
CENTRAL INDEX KEY: 0001845080
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39344
FILM NUMBER: 21630172
MAIL ADDRESS:
STREET 1: C/O FUSION PHARMACEUTICALS, INC.
STREET 2: 270 LONGWOOD ROAD SOUTH
CITY: HAMILTON
STATE: D0
ZIP: L8P OA6
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fusion Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001805890
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 270 LONGWOOD ROAD SOUTH
CITY: HAMILTON
STATE: A6
ZIP: L8P 0A6
BUSINESS PHONE: 289-799-0891
MAIL ADDRESS:
STREET 1: 270 LONGWOOD ROAD SOUTH
CITY: HAMILTON
STATE: A6
ZIP: L8P 0A6
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-11
0
0001805890
Fusion Pharmaceuticals Inc.
FUSN
0001845080
Lee Philina
C/O FUSION PHARMACEUTICALS INC
270 LONGWOOD ROAD SOUTH
HAMILTON
A6
L8P 0A6
ONTARIO, CANADA
1
0
0
0
Stock Option (Right to Buy)
11.75
2021-02-11
4
A
0
30000
0.00
A
2031-02-10
Common Shares
30000
30000
D
The shares subject to this option shall vest and become exercisable in 36 substantially equal monthly installments starting on March 11, 2021.
/s/ Maria Stahl, Attorney-in-Fact
2021-02-12